Patient First: How EQUIPP® Connects Pharmacies and Payers to Drive Better Health Outcomes

The landscape of community pharmacy practice has reached a turning point as health care delivery shifts toward value-based reimbursement. Established by the Centers for Medicare and Medicaid Services (CMS) in 2003, value-based care expanded alongside the Institute for Healthcare Improvement Triple Aim framework in 2007 to align clinical quality with cost optimization.

For years, community pharmacies faced administrative barriers through retroactive direct and indirect remuneration fees. The congressional abolition of these retroactive penalties in 2024 transformed payer strategies, replacing financial punishment with proactive performance incentives.

Because community pharmacy teams interact with patients far more frequently than their provider peers across health care, pharmacies sit at the essential intersection of patients, prescribers, and health plans. Health plans rely on this contact to capture quality data for Medicare Star Ratings and Healthcare Effectiveness Data and Information Set measures.

In an insightful session at the Total Pharmacy Solutions Summit Fall 2026 event, Rosalyn Otting, PharmD, BCGP, senior manager of clinical transformation at PQS by Innovaccer, details how the EQUIPP® platform operationalizes this role. As a neutral third-party platform, EQUIPP connects health plans with over 65,000 pharmacy National Provider Identifiers across 95% of the country. The system standardizes claims data, benchmarks quality scores, surfaces care gaps, and coordinates payment transmission at no extra cost to network pharmacies.

Leveraging these digital tools allows pharmacy leaders to turn daily patient encounters into predictable financial growth. EQUIPP features a bonus-only model that eliminates financial clawbacks or retroactive penalties for uncompleted opportunities as well.

Engaging with these programs delivers immediate clinical impact, as network data shows patients with at least one documented intervention experience a 16% boost on average in medication adherence.

Unlocking Revenue Categories in Value-Based Care

Maximizing financial returns requires understanding the core payment categories within EQUIPP. Medication adherence programs form the largest funding pool, centered on achieving an 80% proportion of days covered across diabetes, hypertension, and statin therapies.

Pharmacies earn check-in bonuses ranging from $5 to $35 per patient conversation. Additionally, the On-Time Fill program requires a single quarterly check-in that triggers automatic refill bonuses of $15 for 28-day supplies or $45 for 84-day supplies. Fourth-quarter revenue is further enhanced by the Final Fill opportunity, which awards a one-time $60 bonus for maintaining patient adherence through December 31.

Beyond adherence, preventive gap closures and clinical interventions offer additional revenue channels. Validated gap closures, such as statin therapy initiation or inhaler prescribing, yield $60 per opportunity.

Counter-side screenings, including blood pressure and blood glucose checks, pay between $35 and $50 per intervention. Formulary conversion programs also reward pharmacies for transitioning patients to lower-cost preferred alternatives, providing bonus dollars for every day covered by the new prescription claim.

Implementing a 4-Part Operational Workflow

Consistently capturing these opportunities requires a structured daily routine. A practical 4-part framework begins with strategic execution, where teams prioritize high-value tasks like early-year formulary switches and late-year final fills.

Building a sustainable workflow involves designating a pharmacy EQUIPP champion and reviewing updated lists regularly when claims data refreshes. Task delegation between pharmacists and technicians distributes workload efficiently, while tools like EQUIPP Copilot display care gap alerts inside dispensing software.

Managing performance metrics prevents pharmacies from missing lucrative year-end bonuses due to minor adherence gaps. Real-time documentation remains the single most critical factor in earning revenue, as late or missing documentation causes unvalidated claims that cannot be processed for payment.

By committing to immediate documentation, pharmacy groups have raised intervention recording rates from 5.3% to 86.6% within 10 weeks. Embracing the core pillars of EQUIPP, including ease of use, active engagement, and expanded earnings, enables pharmacy teams to improve patient care while driving sustainable revenue.

Explore more of our coverage from the Total Pharmacy Solutions Summit Fall 2026: Patient First.